The global bilirubin blood test market is estimated to be valued at USD 1.42 Bn in 2026 and is expected to reach USD 2.28 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7% from 2026 to 2033. The global bilirubin blood test market is a key segment of the in-vitro diagnostics (IVD) market, consisting of laboratory-based and point-of-care (POC) tests that analyze the amount of bilirubin in the blood, a component important for detecting and monitoring liver diseases, hemolytic disorders, bile tract conditions, and neonatal jaundice. Different bilirubin tests are classified as total bilirubin, direct bilirubin, and indirect bilirubin.
The market growth is fueled by the escalating prevalence of chronic and acute liver diseases, as well as the rising occurrences of jaundice in newborns worldwide. In addition, increasing global efforts to promote early disease diagnostics, general health screenings and check-ups further drive adoption of bilirubin blood tests. Technological improvements in medical imaging, clinical lab equipment, and other medical testing instruments enable manufacturers to introduce advanced solutions for more accurate and precise results. Burgeoning healthcare infrastructure in developing countries can be anticipated to drive demand for bilirubin blood test solutions through the predicted timeline.
Market Dynamics
The global bilirubin blood test market is driven by growing prevalence of liver diseases such as hepatitis, cirrhosis and non-alcoholic fatty liver disease (NAFLD) which necessitates regular monitoring of bilirubin levels for diagnosis and management of conditions. Higher rate of neonatal jaundice has also contributed to the growth in the usage of these tests in hospitals and neonatal units. Furthermore, innovative and novel developments such as enhanced accuracy with point-of-care testing equipment, automatic analyzers and innovative and affordable non-invasive transcutaneous bilirubinometers are also leading to the demand for this test.
However, a number of constraints are present in the market, such as high prices of cutting-edge diagnostic systems, lack of health coverage in remote areas, shortage of proficient lab workers, strict regulations for medical devices, and limited coverage by insurance. Nevertheless, expanding healthcare setup, increasing use of home diagnostics, baby screening programs and improved development of biosensor based bilirubin measurement technologies will offer new opportunities for growth in bilirubin blood test market.
Key Features of the Study
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on ‘Bilirubin Blood Test Market' - Global forecast to 2033
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients